查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933280

全球心室辅助装置市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测（2026-2034）

Ventricular Assist Device Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 156 Pages | 商品交期: 请询问到货日

价格

心室辅助装置 (VAD) 市场成长因素

由于全球心臟衰竭盛行率不断上升以及机械循环支持系统的广泛应用，全球心室辅助装置 (VAD) 市场正经历强劲增长。根据 Fortune Business Insights 的数据显示，2025 年全球心室辅助装置市场规模为 14.9 亿美元。预计该市场将从 2026 年的 16.5 亿美元成长到 2034 年的 42.5 亿美元，在预测期（2026-2034 年）内，复合年增长率 (CAGR) 将达到 12.57%。北美地区凭藉先进的医疗基础设施和创新心臟设备的高普及率，在2025年将占全球心室辅助装置（VAD）市场50.18%的市场占有率。

市场概览

心室辅助装置（VAD）是一种植入式机械泵，旨在帮助重度心臟衰竭患者维持心臟功能和血液流动。这些装置透过将血液泵送到全身来辅助心臟的左心室、右心室或双心室。当无法立即进行心臟移植时，VAD被广泛用作移植过渡治疗（BTT）、根治性治疗（DT）、移植过渡治疗（BTC）和復健过渡治疗（BRT）。

全球心臟衰竭负担的加重是推动市场需求的主要因素。根据 "心臟衰竭杂誌" （2023 年）的数据，约有 670 万 20 岁及以上的美国人患有心臟衰竭，预计到 2030 年这一数字将达到 850 万。这将显着增加对心室辅助装置 (VAD) 的需求。

市场趋势

快速的技术创新正在改变 VAD 市场。人工智慧 (AI) 和机器学习在心臟护理中的应用正在改善患者风险评估、手术计划和术后监测。先进的 VAD，例如 HeartMate III 和 DuraHeart，具有体积更小、转速更慢、解剖结构设计更优化以及感染风险更低等特点。

完全植入式系统是主要的创新趋势。例如，获得美国 FDA 批准的美敦力 HVAD 系统无需外部驱动电缆，从而降低了感染风险并提高了患者的活动能力。这些进步有望加速已开发市场和新兴市场的普及。

市场成长驱动因素

心臟衰竭盛行率的上升是最重要的成长因素。西方国家约有1-2%的人口患有心臟衰竭，2020年全球受影响人数超过550万人。人口老化进一步推高了疾病盛行率，使老年人面临更高的心血管疾病风险。

另一个主要因素是心臟移植的漫长等待期。根据美国卫生资源和服务管理局（2022年）的数据，超过105,800名患者在器官移植等待名单上。由于捐赠心臟短缺，心室辅助装置（VAD）越来越多地被用作长期根治性治疗或移植过渡方案。

此外，市场参与者正集中精力进行研发和产品拓展。例如，2021年6月，雅培扩大了其HeartMate 3设备的供应，以满足不断增长的全球需求。

限制因子

儘管成长潜力强劲，但该市场面临与心室辅助装置（VAD）植入成本高昂相关的挑战。在美国，左心室辅助装置（LVAD）植入手术费用高达 17.5 万美元至 20 万美元，这限制了其在对成本敏感地区的普及。与设备相关的併发症，例如泵浦故障、电源问题和感染风险，进一步阻碍了设备的普及。

细分市场分析

依产品划分，左心室辅助装置 (LVAD) 细分市场将在 2026 年占主导地位，市场占有率达 87.10%，这主要得益于其高植入率和 FDA 的批准。

依血流类型划分，连续流装置将在 2026 年占最大占有率，达到 88.81%，这主要归功于其耐用性、低维护成本和改善患者预后的优势。

依应用领域划分，预计根治性治疗 (DT) 将在 2026 年占领先地位，市场占有率达 45.75%，而移植过渡治疗 (BTT) 预计将呈现最高的增长率。

依最终用户划分，医院和门诊手术中心 (ASC) 将引领市场。预计到 2026 年，北美将占 65.95% 的市场占有率，这主要得益于其庞大的手术量。

区域洞察

预计到 2025 年，北美地区的收入将达到 7.5 亿美元，凭藉其先进的心臟护理系统和有利的报销政策，将继续保持领先地位。欧洲将占第二大市场占有率，这主要得益于其强劲的研发投入。亚太地区预计将实现最高的复合年增长率，这主要得益于医疗基础设施的持续改善和政府的支持，尤其是在中国、日本和印度。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 依地区划分的心臟衰竭盛行率（2022/2025）
  • 依地区和国家划分的心臟手术量（2022/2025）
  • 主要公司的新产品发布
  • 主要产业趋势：併购、业务合作等
  • 新冠疫情的影响市场

第五章 全球心室辅助装置市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 左心室辅助装置
    • 右心室辅助装置
    • 双侧心室辅助装置
  • 市场分析、洞察与预测：依血流类型分类
    • 脉动血流
    • 连续血流
  • 市场分析、洞察与预测：依应用分类
    • 移植过渡治疗（BTT）
    • 移植桥接治疗（BTC）（移植桥接候选者）
    • 最终治疗（DT）
    • 康復桥接治疗（BTR）
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和门诊手术中心 (ASC)
    • 专科诊所，其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美心室辅助装置市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲心室辅助装置市场分析、洞察与预测（2021-2034）

  • 依国家/地区
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章 亚太地区心室辅助装置市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲心室辅助装置市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他地区拉丁美洲

第十章：中东和非洲心室辅助装置市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • Berlin HeartOverview
    • ABIOMED
    • Abbott
    • Jarvik Heart, Inc.
Product Code: FBI106377

Growth Factors of ventricular assist device (VAD) Market

The global ventricular assist device (VAD) market is witnessing robust growth due to the rising prevalence of heart failure and increasing adoption of mechanical circulatory support systems worldwide. According to Fortune Business Insights, the global ventricular assist device market size was valued at USD 1.49 billion in 2025. The market is projected to grow from USD 1.65 billion in 2026 to USD 4.25 billion by 2034, registering a strong CAGR of 12.57% during the forecast period (2026-2034). North America dominated the global VAD market with a 50.18% market share in 2025, supported by advanced healthcare infrastructure and high adoption of innovative cardiac devices.

Market Overview

Ventricular assist devices are implantable mechanical pumps designed to support heart function and blood flow in patients suffering from severe heart failure. These devices assist the left, right, or both ventricles of the heart by pumping blood to the rest of the body. VADs are widely used as Bridge-to-Transplant (BTT), Destination Therapy (DT), Bridge-to-Candidacy (BTC), and Bridge-to-Recovery (BTR) solutions when heart transplantation is not immediately feasible.

The increasing global burden of heart failure is a major factor driving demand. As per the Journal of Cardiac Failure (2023), approximately 6.7 million Americans aged 20 and above were affected by heart failure, and this number is expected to reach 8.5 million by 2030, significantly boosting the need for ventricular assist devices.

Market Trends

Rapid technological advancements are transforming the VAD market. The integration of artificial intelligence (AI) and machine learning in cardiac care is improving patient risk assessment, surgical planning, and post-implantation monitoring. Advanced VADs such as HeartMate III and DuraHeart feature smaller sizes, lower rotational speeds, improved anatomic design, and reduced infection risks.

Fully implantable systems represent a key innovation trend. For instance, Medtronic's HVAD system, approved by the U.S. FDA, eliminates external driveline cables, reducing infection risks and improving patient mobility. Such advancements are expected to accelerate adoption across developed and emerging markets.

Market Growth Drivers

The rising prevalence of heart failure remains the most significant growth driver. Heart failure affects nearly 1-2% of the population in Western countries, and globally over 5.5 million individuals were affected in 2020. The growing geriatric population further increases disease prevalence, as elderly individuals are at higher risk of cardiovascular disorders.

Another major driver is the long waiting period for heart transplants. According to the Health Resources & Services Administration (2022), over 105,800 patients were on organ transplant waiting lists. Due to the shortage of donor hearts, VADs are increasingly used as long-term destination therapy and bridge-to-transplant solutions.

Additionally, market players are focusing on R&D initiatives and product expansion. For example, in June 2021, Abbott expanded the supply of its HeartMate 3 device to meet growing global demand.

Restraining Factors

Despite strong growth potential, the market faces challenges related to the high cost of VAD implantation. In the U.S., LVAD implantation procedures can cost between USD 175,000 and USD 200,000, limiting accessibility in cost-sensitive regions. Device-related complications such as pump failure, power supply issues, and infection risks further restrain adoption.

Segmentation Analysis

By product, the Left Ventricular Assist Device (LVAD) segment dominated the market, accounting for 87.10% share in 2026, driven by high implantation rates and FDA approvals.

By flow type, continuous flow devices held the largest share at 88.81% in 2026 due to durability, lower maintenance, and improved patient outcomes.

By application, Destination Therapy (DT) dominated with a 45.75% market share in 2026, while Bridge-to-Transplant is expected to grow at the fastest rate.

By end user, hospitals & ASCs led the market with 65.95% share in 2026, owing to a higher volume of surgical procedures.

Regional Insights

North America generated USD 0.75 billion in revenue in 2025 and continues to dominate due to advanced cardiac care systems and favorable reimbursement policies. Europe holds the second-largest share, driven by strong R&D investments. Asia Pacific is expected to witness the highest CAGR due to expanding healthcare infrastructure and supportive government initiatives, particularly in China, Japan, and India.

Conclusion

The global ventricular assist device market is poised for strong growth, expanding from USD 1.49 billion in 2025 to USD 4.25 billion by 2034. Rising heart failure prevalence, donor heart shortages, and rapid technological advancements in mechanical circulatory support systems are key factors driving market expansion. Although high implantation costs and device-related risks pose challenges, continuous innovation, expanding clinical applications, and improving healthcare infrastructure-especially in Asia Pacific-are expected to create significant long-term opportunities. Overall, the VAD market presents a highly promising outlook for manufacturers, healthcare providers, and investors throughout the forecast period.

Segmentation By Product

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Bi-Ventricular Assist Device

By Type of Flow

  • Pulsatile Flow
  • Continuous Flow

By Application

  • Bridge to Transplant (BTT)
  • Bridge to Candidacy (BTC)
  • Destination Therapy (DT)
  • Bridge to Recovery (BTR)

By End-user

  • Hospitals & ASCs
  • Specialty Clinics & Others

By Geography

  • North America (By Product, By Type of Flow, By Application, and By Country)
    • U.S. (By Product)
    • Canada (By Product)
  • Europe (By Product, By Type of Flow, By Application, and By Country)
    • U.K. (By Product)
    • Germany (By Product)
    • France (By Product)
    • Italy (By Product)
    • Spain (By Product)
    • Rest of Europe (By Product)
  • Asia Pacific (By Product, By Type of Flow, By Application, and By Country)
    • China (By Product)
    • Japan (By Product)
    • India (By Product)
    • Australia (By Product)
    • Southeast Asia (By Product)
    • Rest of Asia Pacific (By Product)
  • Latin America (By Product, By Type of Flow, By Application, and By Country)
    • Brazil (By Product)
    • Mexico (By Product)
    • Rest of Latin America (By Product)
  • Middle East & Africa (By Product, By Type of Flow, By Application, and By Country)
    • GCC (By Product)
    • South Africa (By Product)
    • Rest of the Middle East & Africa (By Product)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Heart Failure, by Region, 2022/2025
  • 4.2. Number of Cardiac Surgeries, By Region/Country, 2022/2025
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Left Ventricular Assist Device
    • 5.1.2. Right Ventricular Assist Device
    • 5.1.3. Bi-Ventricular Assist Device
  • 5.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 5.2.1. Pulsatile Flow
    • 5.2.2. Continuous Flow
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Bridge to Transplant (BTT)
    • 5.3.2. Bridge to Candidacy (BTC)
    • 5.3.3. Destination Therapy (DT)
    • 5.3.4. Bridge to Recovery (BTR)
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Specialty Clinics & Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Left Ventricular Assist Device
    • 6.1.2. Right Ventricular Assist Device
    • 6.1.3. Bi-Ventricular Assist Device
  • 6.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 6.2.1. Pulsatile Flow
    • 6.2.2. Continuous Flow
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Bridge to Transplant (BTT)
    • 6.3.2. Bridge to Candidacy (BTC)
    • 6.3.3. Destination Therapy (DT)
    • 6.3.4. Bridge to Recovery (BTR)
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Specialty Clinics & Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Product
    • 6.5.2. Canada
      • 6.5.2.1. By Product

7. Europe Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Left Ventricular Assist Device
    • 7.1.2. Right Ventricular Assist Device
    • 7.1.3. Bi-Ventricular Assist Device
  • 7.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 7.2.1. Pulsatile Flow
    • 7.2.2. Continuous Flow
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Bridge to Transplant (BTT)
    • 7.3.2. Bridge to Candidacy (BTC)
    • 7.3.3. Destination Therapy (DT)
    • 7.3.4. Bridge to Recovery (BTR)
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Specialty Clinics & Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 7.5.1. Germany
      • 7.5.1.1. By Product
    • 7.5.2. France
      • 7.5.2.1. By Product
    • 7.5.3. U.K.
      • 7.5.3.1. By Product
    • 7.5.4. Italy
      • 7.5.4.1. By Product
    • 7.5.5. Spain
      • 7.5.5.1. By Product
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Product
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Product

8. Asia Pacific Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Left Ventricular Assist Device
    • 8.1.2. Right Ventricular Assist Device
    • 8.1.3. Bi-Ventricular Assist Device
  • 8.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 8.2.1. Pulsatile Flow
    • 8.2.2. Continuous Flow
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Bridge to Transplant (BTT)
    • 8.3.2. Bridge to Candidacy (BTC)
    • 8.3.3. Destination Therapy (DT)
    • 8.3.4. Bridge to Recovery (BTR)
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics & Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 8.5.1. China
      • 8.5.1.1. By Product
    • 8.5.2. Japan
      • 8.5.2.1. By Product
    • 8.5.3. India
      • 8.5.3.1. By Product
    • 8.5.4. Australia
      • 8.5.4.1. By Product
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Product
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Product

9. Latin America Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Left Ventricular Assist Device
    • 9.1.2. Right Ventricular Assist Device
    • 9.1.3. Bi-Ventricular Assist Device
  • 9.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 9.2.1. Pulsatile Flow
    • 9.2.2. Continuous Flow
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Bridge to Transplant (BTT)
    • 9.3.2. Bridge to Candidacy (BTC)
    • 9.3.3. Destination Therapy (DT)
    • 9.3.4. Bridge to Recovery (BTR)
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Specialty Clinics & Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 9.5.1. Brazil
      • 9.5.1.1. By Product
    • 9.5.2. Mexico
      • 9.5.2.1. By Product
    • 9.5.3. Rest of the LATAM
      • 9.5.3.1. By Product

10. Middle East & Africa Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Left Ventricular Assist Device
    • 10.1.2. Right Ventricular Assist Device
    • 10.1.3. Bi-Ventricular Assist Device
  • 10.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 10.2.1. Pulsatile Flow
    • 10.2.2. Continuous Flow
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Bridge to Transplant (BTT)
    • 10.3.2. Bridge to Candidacy (BTC)
    • 10.3.3. Destination Therapy (DT)
    • 10.3.4. Bridge to Recovery (BTR)
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Specialty Clinics & Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 10.5.1. GCC
      • 10.5.1.1. By Product
    • 10.5.2. South Africa
      • 10.5.2.1. By Product
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Product

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Berlin HeartOverview
      • 11.2.1.1. Products & Services
      • 11.2.1.2. SWOT Analysis
      • 11.2.1.3. Recent Developments
      • 11.2.1.4. Strategies
      • 11.2.1.5. Financials (Based on Availability)
    • 11.2.2. ABIOMED
      • 11.2.2.1. Products & Services
      • 11.2.2.2. SWOT Analysis
      • 11.2.2.3. Recent Developments
      • 11.2.2.4. Strategies
      • 11.2.2.5. Financials (Based on Availability)
    • 11.2.3. Abbott
      • 11.2.3.1. Products & Services
      • 11.2.3.2. SWOT Analysis
      • 11.2.3.3. Recent Developments
      • 11.2.3.4. Strategies
      • 11.2.3.5. Financials (Based on Availability)
    • 11.2.4. Jarvik Heart, Inc.
      • 11.2.4.1. Products & Services
      • 11.2.4.2. SWOT Analysis
      • 11.2.4.3. Recent Developments
      • 11.2.4.4. Strategies
      • 11.2.4.5. Financials (Based on Availability)

List of Tables

  • Table 1: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, By Type of Flow, 2021-2034
  • Table 3: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 4: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 8: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Canada Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 13: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 15: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 17: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Germany Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 19: U.K. Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 20: France Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 21: Italy Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Spain Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 23: Scandinavia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 24: Rest of Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 26: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 27: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 29: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Japan Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: India Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 32: China Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 33: Australia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 34: Southeast Asia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 35: Rest of Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 36: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 37: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 38: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 40: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 42: Mexico Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 43: Rest of Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 44: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 45: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 46: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 48: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 50: South Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 51: Rest of Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034

List of Figures

  • Figure 1: Global Ventricular Assist Device Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Ventricular Assist Device Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025 & 2034
  • Figure 4: Global Ventricular Assist Device Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Ventricular Assist Device Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Ventricular Assist Device Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 8: North America Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 9: North America Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 10: North America Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 11: North America Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 13: North America Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 15: North America Ventricular Assist Device Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Ventricular Assist Device Market Value Share (%), By Country, 2025
  • Figure 17: Europe Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Europe Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 19: Europe Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 20: Europe Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 21: Europe Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 23: Europe Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 28: Asia Pacific Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 29: Asia Pacific Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 30: Asia Pacific Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 31: Asia Pacific Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 38: Latin America Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 39: Latin America Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 40: Latin America Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 41: Latin America Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Latin America Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 48: Middle East & Africa Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 49: Middle East & Africa Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 50: Middle East & Africa Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 51: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Ventricular Assist Device Market Share (%), By Company, 2025